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Small supernumerary marker chromosomes (sSMCs)
are defined as structurally abnormal chromosomes
that cannot be identified or characterized by conven-
tional banding cytogenetics, and are generally equal in
size or smaller than a chromosome 20 [1–3]. sSMCs are
present in 0.044% of newborn infants and in 0.075%
of prenatal cases [1,3–5]. About 70% of sSMCs arise
de novo [4], about 70% of sSMCs are derived from acro-
centric chromosomes [1,6], and about 70% cases of 
de novo sSMCs have no phenotypic effects [5]. Prenatal
diagnosis of sSMCs gives rise to difficulties in genetic
counseling, and identification of the nature of the aber-
rant chromosome requires molecular cytogenetic tech-
nologies [5,7–10]. We present our experience of the
prenatal diagnosis and molecular cytogenetic charac-
terization of an sSMC derived from chromosome 22
using fluorescence in situ hybridization (FISH) and array
comparative genomic hybridization (aCGH).
A 42-year-old woman, gravida 2, para 0, underwent
amniocentesis at 18 weeks of gestation because of
advanced maternal age. The woman was phenotypically
normal. She had previously experienced one sponta-
neous abortion. Amniocentesis revealed an sSMC. The
sSMC was C-band positive and nucleolar organizing
region-stain positive. Cytogenetic analysis of the parents
revealed that the mother carried the same sSMC. The
karyotype was 47,XX, +mar mat (Figure 1). FISH using
a centromere 14/22-specific α-satellite DNA probe
(D14Z1/D22Z1) (cep14/22) (Cytocell, Adderbury,
Oxfordshire, UK) and a centromere 22-specific α-
satellite DNA probe (p190.22; D22Z4 probe reported
by Rocchi et al) [11] revealed that the sSMC was posi-
tive for D14Z1/D22Z1 (Figure 2) and positive for two
D22Z4 signals (Figure 3). The parents decided to con-
tinue the pregnancy. A normal female baby weighing
2,828 g was delivered uneventfully at 39 weeks of gesta-
tion. She was developing normally at her 4-year follow-
up. aCGH analysis using Oligo HD Scan (CMDX, Irvine,
CA, USA) showed no genomic imbalance on the peri-
centromeric euchromatic region of chromosome 22
(Figure 4). The sSMC was inv dup(22)(q10). The kary-
otype was 47,XX, +mar .ish der(22) (D14Z1/D22Z1+,
D22Z4++) or 47,XX, +inv dup(22)(q10).
This case shows the limitations of the cep14/22
(D14Z1/D22Z1) probe and the usefulness of the D22Z4
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Figure 1. The G-banded karyotype. mar=marker chromosome.
(p190.22) probe and aCGH in the identification of an
sSMC derived from chromosome 22. The cep14/22
probe, along with cep13/21 and cep15, can be used for
the rapid identification of an acrocentric chromosome-
derived sSMC with positive C-banding and nucleolar
organizing region-staining. However, cep14/22 recog-
nizes the centromeres of both chromosomes 14 and
22. In contrast, the alphoid p190.22 (D22Z4) probe
specifically recognizes the centromere of chromosome
22 under high stringency hybridization conditions [11],
and is therefore useful for differentiating between
chromosomes 22 and 14 when the sSMC is hybridized
with cep14/22 (D14Z1/D22Z1). Other chromosome
22 centromere-specific probes include p22/1:2.1
(D22Z2) [12] and D22Z3 [13,14]. aCGH has the ability
to detect DNA dosage imbalances, including deletions
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Figure 3. Fluorescence in situ hybridization using an α-satellite
probe D22Z4 showing positive hybridization signals on two
chromosomes 22 and the marker chromosome (mar). The
marker chromosome contains two positive signals for
D22Z4.
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Figure 4. Oligonucleotide-based array comparative genomic hybridization using Oligo HD Scan showing no genomic imbalance
in the pericentromeric euchromatic region of chromosome 22.
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Figure 2. Fluorescence in situ hybridization using an α-satellite
probe D14Z1/D22Z1, cep14/22 (spectrum red) showing
positive hybridization signals on two chromosomes 14, two
chromosomes 22 and the marker chromosome (mar).
and duplications, in the pericentromeric euchromatic
regions and is useful for characterizing the genomic
imbalance in the sSMC. Multiplex ligation-dependent
probe amplification (MLPA) is commercially available
for rapid aneuploidy diagnosis. The SALSA MLPA P181
and P182 centromere kits contain one probe for the
short arm and one probe for the long arm of chromo-
somes other than acrocentric chromosomes, and two
probes for the long arm of chromosomes 13, 14, 15, 21
and 22. Each probe is located close to the centromere
of a specific chromosome. The designated regions of
chromosome 22 are CECR5 and CECR1 at 22q11.1 for
the P181 centromere kit, and the designated regions of
chromosome 22 are CECR1 at 22q11.1 and SLC25A18
at 22q11.21 for the P182 centromere kit [15]. A high-
definition MLPA (MLPA-HD) 22q11 kit has recently
been developed to detect copy-number changes at 37
loci encompassing a 3-Mb region on 22q11, including
the critical region for DiGeorge syndrome/velocardio-
facial syndrome (DGS/VCFS), cat eye syndrome (CES)
and commonly deleted distal regions [16].
About 9% of SMCs are derived from chromosome
22 [17]. The 22q11 region is susceptible to chromo-
somal rearrangements leading to DGS/VCFS, CES and
t(11;22)der(22) syndrome, all three of which have
breakpoint regions harboring a similar low-copy repeat
(LCR) known as LCR22 [18,19]. Homologous recom-
bination events between LCR22s during meiosis have
been implicated in DGS/VCFS and CES, and the sites
of chromosome breakage on 11q23 and 22q11 in
der(22) syndrome occur in the unstable AT-rich palin-
dromic sequences leading to nonhomologous recom-
bination mechanisms [19–22]. At least 61 patients with
an sSMC(22) derived from inv dup(22)(q10)-(q11.21)
or min(22)(pter-:p11.2 q11.1:-q11.21:) have been
documented to date, with no clinical findings [23].
However, at least 106 patients with an sSMC(22) derived
from inv dup(22) or inv dup(22)(q11.21)-(q11.23) have
been documented with CES or clinical abnormalities
[23]. CES (OMIM 115470) is usually associated with
an sSMC(22) presenting as inv dup(22)(q11) and has
a highly variable phenotype, including coloboma of
the iris, anal atresia with fistula, down-slanting palpe-
bral fissures, preauricular tags and/or pits, mild hyper-
telorism, cardiac defects, renal malformation, normal
or near-normal mental development in 44% of patients,
mild or moderate mental retardation in 48% of patients
and severe mental retardation in 7% of patients [24–26].
Prenatal diagnosis of sSMC(22) has remained a diag-
nostic challenge and should alert clinicians to the pos-
sibility of CES with the involvement of trisomy or
tetrasomy of the CES chromosome region candidate
genes, such as CECR1-CECR9 at 22q11 [19,26–30].
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